Yduqs Participações S.A. (YDUQ3) Earnings Call Transcripts

Yduqs Participações S.A.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Yduqs Participações S.A. reported strong cash generation of BRL 276 million, marking a 20% return and supporting its ongoing buyback program. Revenue was up 5% year-over-year, driven by robust performance from its premium brands, Ibmec and IDOMED, which grew 23% and 10% respectively. Management maintained its guidance for 2026, projecting free cash flow to equity between BRL 520 million and BRL 620 million, indicating confidence in future growth despite macroeconomic challenges.

Reported metrics

Guidance from management

Management maintained its guidance for 2026, projecting free cash flow to equity between BRL 520 million and BRL 620 million, indicating confidence in future growth despite macroeconomic challenges.

What management said

AI is increasingly a key part of our strategy. We've been talking about key investments that we're making over the years, right? Marcel is setting up the basis so that we could take off and find our data structure so that we can bring features for the company, a leap that we started seeing this year, and Marcel is going to talk about our experience.

Marcelo, thanks for your question. As we've seen in the first quarter, if we look at our margin, the consolidated margin, we had a margin of IDOMED moving sideways. And Ibmec growing up year-over year and Estácio, Wyden was impacted because of the decline in this. Looking ahead, our expectation, there we don't have decline. This, the comparable basis is more favorable now onwards and even numbers there, quarters, w...

What analysts pressed on

Analysts expressed concerns about the sustainability of cash generation and the impact of regulatory changes on distance learning. There were also questions regarding the potential for increased dropout rates amid economic pressures.

Main topics on the call

• Strong Cash Generation — Yduqs achieved record cash generation of BRL 276 million in Q1 2026, a 20% return, which supports its ongoing buyback program. CEO Rossano Marques stated, "this quarter shows the great power of Yduqs portfolio".
• Revenue Growth — The company reported a 5% year-over-year revenue growth, with Ibmec and IDOMED contributing significantly. Ibmec's revenue grew 23%, while IDOMED's grew 10%, demonstrating strong market positioning.
• Guidance Maintenance — Management maintained its guidance for 2026, projecting free cash flow to equity between BRL 520 million and BRL 620 million. This reflects confidence in the company's ability to navigate macroeconomic challenges.
• Improvement in Bad Debt — Yduqs reported a reduction in bad debt, with a drop in days sales outstanding (DSO) to 16 days. This improvement is attributed to better collection strategies and a focus on higher-quality student intake.

Read the full Yduqs Participações S.A. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 37 Yduqs Participações S.A. earnings call transcripts on record, spanning March 13, 2020 to May 8, 2026. Based on this history, Yduqs Participações S.A. reports quarterly. The most recent call on file is dated May 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

YDUQ3

Exchange

BOVESPA

Country

BR

Sector

Consumer Discretionary

Industry

Diversified Consumer Services

Calls on record

37

First call

March 13, 2020

Most recent

May 8, 2026

Reporting cadence

quarterly